153 related articles for article (PubMed ID: 2162670)
1. Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
Biochem Biophys Res Commun; 1990 Jun; 169(2):629-35. PubMed ID: 2162670
[TBL] [Abstract][Full Text] [Related]
2. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
Biochem Pharmacol; 1990 Oct; 40(8):1827-32. PubMed ID: 2173591
[TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of vitamin D receptor levels and osteocalcin synthesis in human osteosarcoma cells.
Mäenpää P; Mahonen A; Pirskanen A
Calcif Tissue Int; 1991; 49 Suppl():S85-6. PubMed ID: 1657330
[TBL] [Abstract][Full Text] [Related]
4. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells.
Mahonen A; Pirskanen A; Keinänen R; Mäenpää PH
Biochim Biophys Acta; 1990 Jan; 1048(1):30-7. PubMed ID: 2153413
[TBL] [Abstract][Full Text] [Related]
6. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways.
Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW
Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551
[TBL] [Abstract][Full Text] [Related]
7. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
[TBL] [Abstract][Full Text] [Related]
8. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
[TBL] [Abstract][Full Text] [Related]
9. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro.
Jurutka PW; Terpening CM; Haussler MR
Biochemistry; 1993 Aug; 32(32):8184-92. PubMed ID: 8394128
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
11. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells.
Pols HA; Birkenhäger JC; Schilte JP; Visser TJ
Biochim Biophys Acta; 1988 Jun; 970(2):122-9. PubMed ID: 2838094
[TBL] [Abstract][Full Text] [Related]
13. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
14. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
15. Effects of diastereoisomers of 1,25-dihydroxyvitamin D3-26,23-lactone on alkaline phosphatase and collagen synthesis in osteoblastic cells.
Ishizuka S; Kiyoki M; Kurihara N; Hakeda Y; Ikeda K; Kumegawa M; Norman AW
Mol Cell Endocrinol; 1988 Jan; 55(1):77-86. PubMed ID: 2834243
[TBL] [Abstract][Full Text] [Related]
16. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
17. Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2).
Morrison NA; Eisman JA
J Bone Miner Res; 1991 Aug; 6(8):893-9. PubMed ID: 1785378
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
Chen TL; Hauschka PV; Feldman D
Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
[TBL] [Abstract][Full Text] [Related]
19. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
Rao LG; Sutherland MK; Reddy GS; Siu-Caldera ML; Uskokovic MR; Murray TM
Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
